Michael Winlo
Chief Executive Officer chez EMYRIA LIMITED
Fortune : 18 698 $ au 31/03/2024
Profil
Michael Winlo is the founder of Cerulean Medical Pty Ltd.
(founded in 2007).
He is currently the Chief Executive Officer, Director & MD at Emyria Ltd., a Non-Executive Director at dorsaVi Ltd.
(starting in 2023), a Director at Linear Clinical Research Ltd., and a Non-Executive Director at Nanoveu Ltd.
(starting in 2023).
Dr. Winlo has an MBA from Stanford University and an undergraduate degree from The University of Western Australia Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EMYRIA LTD
0,13% | 08/08/2023 | 485 794 ( 0,13% ) | 18 698 $ | 31/03/2024 |
Postes actifs de Michael Winlo
| Sociétés | Poste | Début |
|---|---|---|
| EMYRIA LIMITED | Chief Executive Officer | 03/10/2019 |
| NANOVEU LIMITED | Director/Board Member | 28/03/2023 |
| DORSAVI LTD | Director/Board Member | 25/10/2023 |
| Linear Clinical Research Ltd. | Director/Board Member | 01/10/2019 |
Anciens postes connus de Michael Winlo
| Sociétés | Poste | Fin |
|---|---|---|
| Cerulean Medical Pty Ltd. | Founder | - |
Formation de Michael Winlo
| Stanford University | Masters Business Admin |
| The University of Western Australia Business School | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DORSAVI LTD | Electronic Technology |
| NANOVEU LIMITED | Electronic Technology |
| Entreprise privées | 3 |
|---|---|
| Linear Clinical Research Ltd. | |
| Cerulean Medical Pty Ltd. | Health Technology |
| Emyria Ltd. |
